Patients Discontinuing Slimming Medications Regain Pounds Four Times Faster Than Those on Conventional Diets

A recent study indicates that people who stop using popular slimming jabs like Mounjaro or Wegovy may regain lost weight far faster than those who halt conventional lifestyle regimens.

Findings released in a leading health publication points out that while obese people can lose substantial amounts of their total mass while on the medication, the mass is regained at an average rate of 0.8 kg per month after stopping.

"Users using these drugs must be cognizant of the danger of quick weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.

This pace of regain suggests a reversion to pre-treatment weight within about a year and a half.

Comparing Approaches

The research, which reviewed 37 of trials involving thousands of participants, contrasted the outcomes of these new drugs with other pills.

Scientists point out that people who shed pounds through lifestyle changes alone generally experience a less rapid creep back—approximately 100 grams monthly—post-intervention.

The Reason for the Rapid Rebound

Doctors suggest the way of the injections is key to understanding the accelerated regain.

These medications imitate a natural hormone called glucagon-like peptide-1, which controls appetite.

"Long-term administration of GLP-1 levels several times higher than normal could lead to the system to produce less of its own natural hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication means hunger is no longer kept in check, making excessive eating a significant risk."

A Lifelong Condition?

Health authorities suggest the jabs for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.

A number of clinicians argue that, given the likelihood of weight regain, the therapy should be considered long-term.

This view is reinforced by drug manufacturers, who state that the results "highlight the persistent character of obesity," comparing it to managing conditions like hypertension.

User Experiences

People who have come off the jabs explain a intense return of hunger.

"I experienced something that goes on and you become starving," described one woman.

This difficulty is exacerbated if users have not established permanent dietary or behavioural modifications during therapy.

Significant Adoption

Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.

• Adoption is higher among women than men.
• The 40s and 50s age group shows the greatest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

Finally, experts caution that while the jabs are potent agents for weight loss, they are not a standalone fix and long-term success likely depends on integrated lifestyle management.